Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma-Reference-Cited by-同舟云学术

Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma

Published:2016-05-13 Issue:4 Volume:50 Page:329-336
ISSN:1869-3474
Container-title:Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Nucl Med Mol Imaging

Author:

Jeong Geum-Cheol,Song Minchul,Park Hee Jeong,Min Jung-Joon,Bom Hee-Seung,Cho Sang-Geon,Park Ki Seong,Kang Sae-Ryung,Kim Jahae,Song Ho-Chun,Kwon Seong Young

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s13139-016-0421-1.pdf

Reference28 articles.

1. Park HJ, Jeong GC, Kwon SY, et al. Stimulated serum thyroglobulin level at the time of first dose of radioactive iodine therapy is the most predictive factor for therapeutic failure in patients with papillary thyroid carcinoma. Nucl Med Mol Imaging. 2014;48:255–61.

2. Lee JI, Chung YJ, Cho BY, et al. Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma. Surgery. 2013;153:828–35.

3. Webb RC, Howard RS, Stojadinovic A, et al. The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients. J Clin Endocrinol Metab. 2012;97:2754–63.

4. Kendler DB, Vaisman F, Corbo R, Martins R, Vaisman M. Pre-ablation stimulated thyroglobulin is a good predictor of successful ablation in patients with differentiated thyroid cancer. Clin Nucl Med. 2012;37:545–9.

5. Vaisman A, Orlov S, Yip J, et al. Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma. Head Neck. 2010;32:689–98.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple Metastatic Lesions on a Post-Ablative Whole-Body Scan Despite a Negative Serum Thyroglobulin Level in a Patient With Papillary Thyroid Cancer;Journal of Endocrinology and Metabolism;2024-04

2. Post-Surgical Indications to Radioiodine Treatment and Potential Risk Factors for Post-Treatment Recurrence in Patients with Intermediate-Risk Differentiated Thyroid Carcinoma;Journal of Personalized Medicine;2023-04-29

3. Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer;Scientific Reports;2023-01-19

4. A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [18F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer;Diagnostics;2021-05-06

5. The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer;The Korean Journal of Internal Medicine;2020-09-01